E-mail: salek.david@fnbrno.cz
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikovaná abstrakta
- CLINICAL FINDINGS AND TREATMENT OF ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: THE ANALYSIS OF THE 1425 PATIENTS INCLUDED IN CZECH LYMPHOMA PROJECT (CLP)
- DIAGNOSTIC AND THERAPEUTIC APPROACH TO SMALL LYMPHOCYTIC LYMPHOMA (SLL): EXPERIENCE OF CZECH LYMPHOMA STUDY GROUP
- First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy
- First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant
- Frontline Intensive Chemotherapy Brings Survival Benefit In Young, Risky Patients With Follicular Lymphoma: Pair-Matched Analysis From The Czech Lymphoma Study Group (CLSG) Database
- HIGH-DOSE CYTARABINE AND MITOXANTRONE ±RITUXIMAB FOR COLLECTION OF PERIPHERAL BLOOD STEM CELLS IN HIGH-GRADE NON-HODGKINS´ LYMPHOMA. SINGLE CENTER EXPERIENCE WITH FILGRASTIM BIOSIMILARS
- HOW TO TREAT B-CELL LYMPHOMA, UNCLASSIFIABLE, WITH FEATURES INTERMEDIATE BETWEEN DIFFUSE LARGE B-CELL LYMPHOMA AND BURKITT LYMPHOMA. SINGLE CENTRE EXPERIENCE.
- INCIDENCE, CHARACTERISTICS AND OUTCOME OF CNS INVOLVEMENT IN MANTLE CELL LYMPHOMA: A MULTICENTRE RETROSPECTIVE ANALYSIS FROM THE EUROPEAN MANTLE CELL LYMPHOMA NETWORK
- Mantle Cell Lymphoma International Prognostic Score Is Valid and Confirmed in Unselected Cohort of Patients Treated in Rituximab Era
- Median Absolute Lymphocyte Count Independently Predicts Survival of Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-Chemotherapy: Analysis of 651 Patients Included In the Czech Lymphoma Project
- MONITORING OF MINIMAL RESIDUAL DISEASE IN MANTLE CELL LYMPHOMA
- NON-HODGKIN LYMPHOMA SUBTYPES CLASSIFICATION USING FOCUSED MICROARRAY
- Observational Study Alternating R-CHOP21 and R-Cytarabine (3+3 Cycles) for Patients with Newly Diagnosed Mantle Cell Lymphoma Not Eligible for High-Dose Therapy: A Czech Lymphoma Study Group Trial Preliminary Results
- PCR DETECTION OF NON-MTC T(11;14) TRANSLOCATIONS IN MANTLE CELL LYMPHOMA
- PREDICTIVE VALUE OF EARLY 18FDG POSITRON EMISSION TOMOGRAPHY (PET) IN HIGH-RISK AGGRESSIVE B-LYMPHOMAS TREATED WITH RITUXIMAB, INTENSIVE INDUCTION THERAPY AND AUTOLOGOUS TRANSPLANTATION
- ROLE OF FDG-PET IN T-CELL AND NK-CELL LYMPHOMAS
- THE LATE CARDIOTOXICITY OF DOXORUBICIN CONTAINING REGIMENS IN THE TREATMENT OF MALIGNANT LYMPHOMAS
- The Mystery of FDG-PET Avidity In Follicular Lymphoma. Does Microenvironment Play the Key Role?
- The Outcome of Mantle Cell Lymphoma patients after Treatment Failure and Prognostic value of Secondary Mantle Cell International Prognostic Index (sec MIPI)
Články v Klinické onkologii
- Fludarabin v léčbě folikulárních lymfomů
- Hodnocení klinického stadia a léčebné odpovědi u maligních lymfomů – doporučení Kooperativní lymfomové skupiny na základě revidovaných kritérií z roku 2014 (Luganská klasifikace)
- Určování rozsahu onemocnění u non-Hodgkinových lymfomů – doporučení Kooperativní lymfomové skupiny
